213 related articles for article (PubMed ID: 24570391)
1. MicroRNA expression might predict prognosis of epithelial hepatoblastoma.
Gyugos M; Lendvai G; Kenessey I; Schlachter K; Halász J; Nagy P; Garami M; Jakab Z; Schaff Z; Kiss A
Virchows Arch; 2014 Apr; 464(4):419-27. PubMed ID: 24570391
[TBL] [Abstract][Full Text] [Related]
2. High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.
Weiss JBW; Wagner AE; Eberherr C; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
Cancer Biomark; 2020; 28(3):321-328. PubMed ID: 32390604
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance.
Ecevit ÇÖ; Aktaş S; Tosun Yildirim H; Demirağ B; Erbay A; Karaca İ; Çelik A; Demir AB; Erçetin AP; Olgun N
J Pediatr Hematol Oncol; 2019 Jan; 41(1):7-12. PubMed ID: 29889802
[TBL] [Abstract][Full Text] [Related]
4. High tricellulin expression is associated with better survival in human hepatoblastoma.
Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
von Frowein J; Pagel P; Kappler R; von Schweinitz D; Roscher A; Schmid I
Hepatology; 2011 Mar; 53(3):833-42. PubMed ID: 21319197
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication.
Chopra A; Iyer VK; Agarwala S; Mathur SR; Aron M; Gupta SD; Verma K
Pediatr Surg Int; 2010 Dec; 26(12):1173-8. PubMed ID: 20803149
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
Liu W; Chen S; Liu B
Pediatr Surg Int; 2016 Nov; 32(11):1059-1065. PubMed ID: 27601233
[TBL] [Abstract][Full Text] [Related]
8. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
Jiao C; Jiao X; Zhu A; Ge J; Xu X
J Pediatr Surg; 2017 Apr; 52(4):618-624. PubMed ID: 28277300
[TBL] [Abstract][Full Text] [Related]
10. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
Liu Y; Song J; Liu Y; Zhou Z; Wang X
J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
[TBL] [Abstract][Full Text] [Related]
12. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology.
Rugge M; Sonego F; Pollice L; Perilongo G; Guido M; Basso G; Ninfo V; Pennelli N; Gambini C; Guglielmi M; Fabiano A; Leandro G; Keeling JW
Liver; 1998 Apr; 18(2):128-33. PubMed ID: 9588772
[TBL] [Abstract][Full Text] [Related]
13. Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.
Jiao C; Zhu A; Jiao X; Ge J; Xu X
J Pediatr Surg; 2016 Aug; 51(8):1355-61. PubMed ID: 27046304
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma.
Hino Y; Kohashi K; Tamaki A; Kawakubo N; Hamada H; Fukuhara M; Shibui Y; Tajiri T; Oda Y
Pathol Res Pract; 2024 Jun; 258():155348. PubMed ID: 38761648
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
16. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of molecular genetic alterations in hepatoblastoma.
von Schweinitz D; Kraus JA; Albrecht S; Koch A; Fuchs J; Pietsch T
Med Pediatr Oncol; 2002 Feb; 38(2):104-8. PubMed ID: 11813174
[TBL] [Abstract][Full Text] [Related]
18. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
19. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.
Bera G; Das RN; Roy P; Ghosh R; Islam N; Mishra PK; Chatterjee U
Pediatr Surg Int; 2017 Sep; 33(9):961-970. PubMed ID: 28631020
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.
Lendvai G; Szekerczés T; Gyöngyösi B; Schlachter K; Kontsek E; Pesti A; Patonai A; Werling K; Kovalszky I; Schaff Z; Kiss A
Pathol Oncol Res; 2019 Jul; 25(3):1103-1109. PubMed ID: 30411298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]